calcific aortic stenosis

临床试验

计划入组 1,101 人 · 首次发布于 2017 年 11 月 17 日

尚未招募

NCT07256197

PCSK9 Inhibitors in the Treatment of Calcific Aortic Stenosis

计划入组 160 人 · 首次发布于 2025 年 12 月 1 日

招募中

NCT06337227

Potential Role of Sirtuins As Epigenetic Biomarkers of the Patient with Atherosclerosis or Calcific Aortic Stenosis

计划入组 3 人 · 首次发布于 2024 年 3 月 29 日

药物

查看全部 125 →

olfactory mucosa-derived mesenchymal stem cells therapy (tracheal stenosis/laryngeal stenosis)

Small Molecule

Investigational

Limaprost

相关疾病：Ischemic Ulcers, Pain caused by Ischaemia，另有 1 项

C₂₂H₃₆O₅ · Rx

Small Molecule

Approved

Propranolol(Hemangeol, Hemangiol, Inderal, Innopran)

生产企业：Akrimax pharmaceuticals llc, Glaxosmithkline llc，另有 34 家

相关疾病：Akathisia caused by antipsychotic use, Angina Pectoris，另有 19 项

C₁₆H₂₁NO₂ · Rx

机构

查看全部 93 →

THUBRIKAR AORTIC VALVE INC

United States

Bolton Medical, Inc.

United States

Artivion

United States

资讯

查看全部 365 →

10个月前

Kardigan's Ataciguat Shows Promise in Phase 2 Trial for Moderate Calcific Aortic Valve Stenosis

11个月前

Anteris Technologies Receives European Regulatory Clearance for DurAVR Global Pivotal Trial in Aortic Stenosis

4个月前

临床试验

Effective Management of Calcific Aortic Stenosis in the Elderly

PCSK9 Inhibitors in the Treatment of Calcific Aortic Stenosis

Potential Role of Sirtuins As Epigenetic Biomarkers of the Patient with Atherosclerosis or Calcific Aortic Stenosis

药物

olfactory mucosa-derived mesenchymal stem cells therapy (tracheal stenosis/laryngeal stenosis)

Limaprost

Propranolol(Hemangeol, Hemangiol, Inderal, Innopran)

机构

THUBRIKAR AORTIC VALVE INC

Bolton Medical, Inc.

Artivion

资讯

Kardigan's Ataciguat Shows Promise in Phase 2 Trial for Moderate Calcific Aortic Valve Stenosis

Anteris Technologies Receives European Regulatory Clearance for DurAVR Global Pivotal Trial in Aortic Stenosis

Anteris Technologies Initiates U.S. Enrollment in PARADIGM Trial for Novel Biomimetic Heart Valve